Skip to main content

Author: World Health Organization (WHO)


WHO Consolidated Guideline on Self-Care Interventions for Health

This guidance from the World Health Organization (WHO) aims to provide a people-centred, evidence-based normative guideline that will support individuals, communities, and countries with quality health services and self-care interventions, based on PHC strategies, comprehensive essential service packages and people-centredness. The guidance includes a “strong” recommendation for self-administered injectable contraception, stating that this should be made available as an additional approach to deliver injectable contraception for individuals of reproductive age.

Institutional Author(s): World Health Organization (WHO)
Publication date: June, 2021

WHO’s Essential Medicines and Health Products Information Portal

This website portal serves as a repository for full-text articles about all aspects of international drug and health product registration.

Institutional Author(s): World Health Organization (WHO)
Publication date: December, 2020

Web page

Maintaining essential health services: operational guidance for the COVID-19 context

This publication recommends practical actions that countries can take at national, subregional and local levels to reorganize and safely maintain access to high-quality, essential health services in the pandemic context. The guidance outlines strategies governments should take to ensure populations retain access to essential health services, including sexual and reproductive health care, during and beyond the current COVID-19 pandemic. It is intended for decision-makers and managers at the national and subnational levels.

Institutional Author(s): World Health Organization (WHO)
Publication date: June, 2020

WHO Guideline: recommendations on digital interventions for health system strengthening

This guideline presents recommendations based on a critical evaluation of the evidence on emerging digital health interventions that are contributing to health system improvements, based on an assessment of the benefits, harms, acceptability, feasibility, resource use and equity considerations.

Institutional Author(s): World Health Organization (WHO)
Publication date: June, 2019

Guide Web page

Family Planning: A Global Handbook for Providers

WHO’s global family planning handbook provides high-quality, up-to-date guidance for health-care professionals working in low- and middle-income countries.

Institutional Author(s): World Health Organization (WHO)
Publication date: June, 2018

Guide Web page

WHO Selected practice recommendations for contraceptive use

Along with WHO’s Medical eligibility criteria for contraceptive use, this is one of two evidence-based guidance documents of the WHO’s initiative to develop and implement family planning guidelines for national programs. This document provides guidance for how to use contraceptive methods safely and effectively once they are deemed to be medically appropriate. Safety considerations include common barriers to safe, correct and consistent use of contraception and the benefits of preventing unintended or unwanted pregnancy.

Institutional Author(s): World Health Organization (WHO)
Publication date: June, 2016

Guide Web page

Medical Eligibility Criteria for Contraceptive Use

The MEC provides guidance to national family planning and reproductive health programmes in the preparation of guidelines for the delivery of contraceptive services. The guide provides information on the safety and use of intramuscular and subcutaneous DMPA.

Institutional Author(s): World Health Organization (WHO)
Publication date: August, 2015

Guide Web page

The WHO Collaborative Registration Procedure for Medicines in Developing Countries

This thesis provides an in-depth review of key World Health Organization-led procedures for registering medicines in developing countries, including prequalification, the concept of essential medicines, and collaborative registration.

Institutional Author(s): World Health Organization (WHO)
Individual Author(s): Stefanie Haas
Publication date: June, 2015

Report The WHO Collaborative Registration Procedure for Medicines in Developing Countries

WHO Prequalification of Medicines Programme: WHO launches the PQP Collaborative Registration Procedure

A concise summary of WHO’s Collaborative Registration Procedure describes the advantages of this program as well as experiences and lessons learned during the launch of this activity in 2012.

Institutional Author(s): World Health Organization (WHO)
Publication date: December, 2013

Brief WHO Prequalification of Medicines Programme: WHO launches the PQP Collaborative Registration Procedure

Nine Steps for Developing a Scaling-Up Strategy

The aim of this 35-page guide is to facilitate systematic planning for scaling up. It is intended for program managers, researchers, and technical support agencies who are seeking to scale-up health service innovations that have been tested in pilot projects or other field tests and proven successful.

Institutional Author(s): World Health Organization (WHO)
Publication date: June, 2010

Guide Web page